Bristol Paying $2 Bil. For ImClone C225; New Milestone For Inlicensing Deals?

 
• By The Pink Sheet
  
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Archive

More from Pink Sheet